Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Assets (2011 - 2026)

Immutep's (IMMP) quarterly Assets came in at $59.1 million in Q2 2026, down 41.25% on a YoY basis from $100.5 million in Q2 2025, and down 38.89% quarter-over-quarter from $96.6 million in Q4 2025.

Analysis

Immutep (IMMP) Assets (2011 - 2026) Analysis & Trends

Immutep (IMMP) has reported Assets for 16 consecutive years, with $59.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets fell 41.25% year-over-year to $59.1 million; the trailing twelve-month figure through Jun 2026 stood at $59.1 million (down 41.25% YoY), and the FY2026 full-year result was $59.1 million, down 41.25% from the prior year.
  • Assets retreated to $59.1 million in Q2 2026 per IMMP's latest filing, from $96.6 million in the prior quarter.
  • Across five years, Assets topped out at $132.8 million in Q2 2024 and bottomed at $56.5 million in Q4 2022.
  • Historically, Assets has averaged $90.8 million across 5 years, with a median of $96.6 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Assets soared 47.96% in 2024, then plunged 41.25% in 2026.
  • Over 5 years, Assets stood at $56.5 million in 2022, then surged by 42.6% to $80.6 million in 2023, then surged by 47.96% to $119.2 million in 2024, then dropped by 18.94% to $96.6 million in 2025, then sank by 38.89% to $59.1 million in 2026.
  • According to Business Quant data, Assets over the past three periods registered $59.1 million, $96.6 million, and $100.5 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 10.03 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.31 Bn
10 Immutep 51.68 Mn 51.68 Mn - 59.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.07 Mn
Dec 31, 2025 96.65 Mn
Jun 30, 2025 100.54 Mn
Dec 31, 2024 119.23 Mn
Jun 30, 2024 132.85 Mn
Dec 31, 2023 80.59 Mn
Jun 30, 2023 98.55 Mn
Dec 31, 2022 56.51 Mn
Jun 30, 2022 73.18 Mn
Dec 31, 2021 87.57 Mn
Jun 30, 2021 63.17 Mn
Dec 31, 2020 55.90 Mn
Jun 30, 2020 30.54 Mn
Dec 31, 2019 29.35 Mn
Jun 30, 2019 28.40 Mn
Dec 31, 2018 34.61 Mn
Jun 30, 2018 35.58 Mn
Dec 31, 2017 28.49 Mn
Jun 30, 2017 26.27 Mn
Mar 31, 2017 26.78 Mn